Back to Search
Start Over
Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.
Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.
- Source :
- Medical Science Monitor; 2017, Vol. 23, p3318-3323, 6p, 1 Black and White Photograph, 3 Charts, 2 Graphs
- Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 12341010
- Volume :
- 23
- Database :
- Complementary Index
- Journal :
- Medical Science Monitor
- Publication Type :
- Academic Journal
- Accession number :
- 127261414
- Full Text :
- https://doi.org/10.12659/MSM.902077